- Home
- DTCK vs ERNA Comparison
DTCK vs ERNA Comparison
Compare DTCK & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- ERNA
- Stock Information
- Founded
- DTCK 1999
- ERNA 2018
- Country
- DTCK Singapore
- ERNA United States
- Employees
- DTCK N/A
- ERNA N/A
- Industry
- DTCK Farming/Seeds/Milling
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- DTCK Industrials
- ERNA Health Care
- Exchange
- DTCK Nasdaq
- ERNA Nasdaq
- Market Cap
- DTCK 14.7M
- ERNA 14.2M
- IPO Year
- DTCK 2023
- ERNA N/A
- Fundamental
- Price
- DTCK $0.57
- ERNA $0.18
- Analyst Decision
- DTCK
- ERNA
- Analyst Count
- DTCK 0
- ERNA 0
- Target Price
- DTCK N/A
- ERNA N/A
- AVG Volume (30 Days)
- DTCK 18.0K
- ERNA 429.2K
- Earning Date
- DTCK 04-30-2025
- ERNA 06-13-2025
- Dividend Yield
- DTCK N/A
- ERNA N/A
- EPS Growth
- DTCK N/A
- ERNA N/A
- EPS
- DTCK N/A
- ERNA N/A
- Revenue
- DTCK $132,369,000.00
- ERNA $535,000.00
- Revenue This Year
- DTCK N/A
- ERNA N/A
- Revenue Next Year
- DTCK N/A
- ERNA N/A
- P/E Ratio
- DTCK N/A
- ERNA N/A
- Revenue Growth
- DTCK N/A
- ERNA 365.22
- 52 Week Low
- DTCK $0.40
- ERNA $0.15
- 52 Week High
- DTCK $1.42
- ERNA $2.63
- Technical
- Relative Strength Index (RSI)
- DTCK 46.90
- ERNA 35.43
- Support Level
- DTCK $0.47
- ERNA $0.16
- Resistance Level
- DTCK $0.61
- ERNA $0.25
- Average True Range (ATR)
- DTCK 0.04
- ERNA 0.03
- MACD
- DTCK 0.00
- ERNA -0.01
- Stochastic Oscillator
- DTCK 48.75
- ERNA 22.22
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.